6 completed, 2 unknown. 3 Phase 2, 2 Not applicable, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Prostatic Intraepithelial Neoplasia: new trials by email Literature Review of Prostatic Intraepithelial Neoplasia trials Research Report on Prostatic Intraepithelial Neoplasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bone Augmentation Using Particulated Biomaterial and Autogenous Bone, Stabilized by Collagen Membrane and Pins (PaMP) Biopsy, Computerized Tomography, Standardized periapical radiographs - Alveolar Bone Grafting, Bone Augmentation | Not applicable | Unknown | Pedro Tortamano | 24 | 2015-04-01 | 2015-04-02 |
| The Effects of Lycopene on High Risk Prostatic Tissue Lycopene 30mg, Placebo - Intraepithelial Prostatic Neoplasia, Prostatic Neoplasms | Phase 2 | Completed | University of Illinois at Chicago | 66 | 2006-02-01 | 2019-11-19 |
| Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma Prostate Cancer, Benign Prostatic Hyperplasia | Unknown | ProteoSys AG | 750 | 2005-09-01 | 2007-02-05 | |
| Broccoli, Peas and PIN Broccoli, Peas - Prostatic Intraepithelial Neoplasia | Not applicable | Completed | Quadram Institute Bioscience | 22 | 2005-04-01 | 2007-09-27 |
| Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia) Toremifene 20 mg, Placebo - Preneoplastic Conditions, Prostatic Intraepithelial Neoplasia | Phase 3 | Completed | GTx | 1589 | 2005-01-01 | 2023-06-12 |
| Finasteride and Flutamide in Pre-surgical Trial in Prostate Cancer. Flutamide, Finasteride, Placebo - Prostate Cancer, Prostatic Intraepithelial Neoplasia | Phase 2 / Phase 3 | Completed | Ente Ospedaliero Ospedali Galliera | 125 | 2004-01-01 | 2024-09-19 |
| A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial Neoplasia - Lyc-O-Mato (dietary supplement, 30 mg lycopene/day), - Certagen (multivitamins with minerals) - Prostatic Intraepithelial Neoplasia | Phase 1 | Completed | University of Pittsburgh | 80 | 2003-07-01 | 2015-05-27 |
| A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN) GTX-006 (Acapodene) - Prostatic Intraepithelial Neoplasia | Phase 2 | Completed | GTx | 500 | 2001-04-01 | 2013-11-15 |
Prostatic Neoplasms (3) · Neoplasms (2) · Male Urogenital Diseases (1) · Precancerous Conditions (1) · Prostatic Hyperplasia (1)
Carcinoma (8) · Carcinoma in Situ (8) · Neoplasms by Histologic Type (8) · Neoplasms, Glandular and Epithelial (8) · Neoplasms (6) · Genital Diseases (3) · Genital Diseases, Male (3) · Genital Neoplasms, Male (3) · Neoplasms by Site (3) · Prostatic Diseases (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Male Urogenital Diseases (2)
Lycopene (2) · Toremifene (2) · Biopsy (1) · Dietary Supplements (1) · Finasteride (1) · Flutamide (1) · Geritol (1) · Minerals (1) · Sugars (1)
GTx (2) · Ente Ospedaliero Ospedali Galliera (1) · Pedro Tortamano (1) · ProteoSys AG (1) · Quadram Institute Bioscience (1) · University of Illinois at Chicago (1) · University of Pittsburgh (1)
United States (3) · Argentina (1) · Canada (1) · Italy (1) · Trinidad and Tobago (1)
Andrea De Censi, MD (1) · Clareann H Bunker, PhD (1) · Lewis H Kuller, MD (1) · Martin Schostak, PD Dr. (1) · Pedro Tortamano, PHD (1) · Peter H Gann, MD, ScD (1) · Richard F Mithen, PhD (1) · Samir Taneja, MD (1)
PMID 18596959, PMID 19012935, PMID 23295793
R01CA090759 (1)